What’s Going On With Tempus AI Stock Monday? – Tempus AI (NASDAQ:TEM)

Tempus AI Inc TEM stock is trading marginally lower on Monday, showing little movement after a 7% gain last week. On Friday, HC Wainwright & Co. analyst Yi Chen reiterated a Buy rating on the artificial intelligence and precision medicine company, raising the price target to $98 from $90.

What To Know: The company recently received 510(k) clearance from the U.S. Food and Drug Administration for its updated Tempus Pixel, an AI-powered cardiac imaging platform. The update enhances the device’s cardiac MR imaging analysis capabilities by allowing the generation of T1 and T2 inline maps directly from raw MRI data.

This new functionality provides clinicians with precise numerical values to detect conditions such as fibrosis, inflammation, or edema, which might otherwise go undetected. Per the company, The AI-enabled radiology of Tempus Pixel aims to improve diagnostic accuracy and efficiency, empowering clinicians to make faster, more informed decisions and deliver personalized patient care.

Benzinga Edge Rankings: Benzinga Edge stock rankings give you four critical scores to help you identify the strongest and weakest stocks to buy and sell.

Price Action: According to data from Benzinga Pro, TEM shares are trading lower by 1.28% to $85.27 Monday. The stock has a 52-week high of $91.45 and a 52-week low of $31.36.

How To Buy TEM Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Tempus AI’s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

Image: Shutterstock